AMERICAN REGENT, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1967-01-01
- Employees
- 501
- Market Cap
- -
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT00236964
Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 224
- Registration Number
- NCT00236951
Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant Melanoma
Not Applicable
Completed
- Conditions
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 575
- Registration Number
- NCT00087776
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath